Porvair Filtration Group, an international leader in high performance filtration and separation materials and products for the medical, pharmaceutical and life science industries will be exhibiting at the Medica/CompaMed 2012 trade show in Düsseldorf, Germany in Hall 8a at Stand F-08.
Porvair will showcase regulatory approved BioVyon™ sintered porous plastic materials and its flagship product, Chromatrap®, based upon proprietary BioVyon™ technology and used by researchers to identify cancer biomarkers.
BioVyon™ porous materials are used for in vitro filtration, separation, venting and wicking applications in the medical, pharmaceutical and life science industries. Through a combination of new material developments, including composites and surface modified structures, and working in partnership with OEM and end user customers, Porvair is able to achieve optimum design and regulatory approval.
Recent developments have included nasal spray filters, drug delivery filters and catheter vents. Manufactured in ISO-accredited cleanrooms, BioVyon™ materials exhibit very low particle shedding, low extractables and low bioburden, making them ideally suited to critical applications.
The Chromatrap® product, a novel chromatin immunoprecipitation (ChIP) assay, utilises surface modified BioVyon™ material to which Protein A or Protein G has been chemically bound. The Chromatrap® solid phase porous structure captures antibody-tagged DNA-protein complexes associated with cancers. This technology is paving the way in the quest for targeted cancer treatments and personalised medicines.
Porvair Filtration Group